A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

July 29, 2018

Study Completion Date

July 29, 2018

Conditions

Heathy Volunteer

Interventions

DRUG

CC-90001

DRUG

Omeprazole

DRUG

Midazolam

DRUG

Warfarin

DIETARY_SUPPLEMENT

Vitamin K

DRUG

Rosuvastatin

DRUG

Metformin

DRUG

Digoxin

DRUG

Nintedanib

Trial Locations (1)

Covance Clinical Research Unit, Daytona Beach